Sopharma Trading - Bound to healthy growth - 9m 2014

Bound to healthy growth

11.8% CAGR for the last seven years; 7.15% average dividend yield in the last five years. Sopharma Trading firmly leads the Bulgarian pharmaceuticals wholesale market. Stable market growth of 3-5% to support the Company’s top line while the expected 80% increase in government healthcare spending and the hospitals’ need tо invest in new equipment to further boost growth and offer higher profitability.